Cargando…
The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis
Ovarian cancer is the most lethal gynaecological cancer, and resistance of platinum‐based chemotherapy is the main reason for treatment failure. The aim of the present study was to identify candidate genes involved in ovarian cancer platinum response by analysing genes from homologous recombination...
Autores principales: | Xing, Linan, Mi, Wanqi, Zhang, Yongjian, Tian, Songyu, Zhang, Yunyang, Qi, Rui, Lou, Ge, Zhang, Chunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520306/ https://www.ncbi.nlm.nih.gov/pubmed/32762026 http://dx.doi.org/10.1111/jcmm.15567 |
Ejemplares similares
-
PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients
por: Xing, Linan, et al.
Publicado: (2021) -
Comprehensive analysis of mRNA‐level and miRNA‐level subpathway activities for identifying robust ovarian cancer prognostic signatures
por: Tian, Songyu, et al.
Publicado: (2020) -
Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer
por: Zhang, Yongjian, et al.
Publicado: (2020) -
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016) -
Characterization of global research trends and prospects on platinum-resistant ovarian cancer: a bibliometric analysis
por: Duan, Yuanqiong, et al.
Publicado: (2023)